Cyclops™
Pre-filled
dry Powder inhaler

Cyclops™ is a state-of-the-art, easy to use, pre-filled DPI that is developed by PureIMS for inhalation powders.
Because of its simple yet
sophisticated proprietary design it can be produced in a cost-effective way.
Cyclops™ is available in single & multi use versions.
Upon inhalation it uses the patient’s breath to disperse the dry powder formulation into small particles appropriately sized for deep lung deposition. Cyclops™ has several advantages compared to standard-of-care DPIs across key therapeutic areas. These attributes enable the hygienic and effective use on a worldwide scale. One product, Colistin Cyclops™, is already available to patients and reimbursed under a named patient regimen for the treatment of cystic fibrosis.
HIGHLY PREFERRED BY PATIENTS
LATEST NEWS

PureIMS winning the LIFE Science Innovation Award!
Tuesday September 26 was an exciting day for the PureIMS team. Not

PureIMS initiates dose-finding study with Levodopa Cyclops™ dry powder inhaler
Following a successful funding round in April of this year
PureIMS secures new investment round to develop lead inhalation product and facilitate partnering activities
PureIMS today announced it has secured a new investment round.

PureIMS names Frank Lambert to advance commercialization of its Cyclops™ Dry Powder Inhaler (DPI)
Roden — February 10, 2023 — PureIMS, a clinical stage pharmaceutical

Drug Delivery to the Lungs (DDL) poster on Epinephrine Cyclops™
Check out our scientific poster for DDL2022 on Epinephrine Cyclops™!